Teladan Prima Agro corrects IPO fund-use report for period ended June 30, 2026
Bitget2026/10/08 10:22PT Teladan Prima Agro issued a correction to its prior report on changes in the use of IPO proceeds for the period ended June 30, 2026. The corrected filing shows gross IPO proceeds of IDR 300.36 billion, costs of IDR 14.75 billion, net proceeds of IDR 285.6 billion. It reported full deployment of net proceeds, leaving no remaining funds. The use-of-funds change was endorsed at the annual shareholders’ meeting on April 16, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PT Teladan Prima Agro Tbk published the original content used to generate this news brief via Indonesia Stock Exchange (IDX) (Ref. ID: 32164090) on October 08, 2026, and is solely responsible for the information contained therein.
- PT Teladan Prima Agro issued a correction to its prior report on changes in the use of IPO proceeds for the period ended June 30, 2026.
- The corrected filing shows gross IPO proceeds of IDR 300.36 billion, costs of IDR 14.75 billion, net proceeds of IDR 285.6 billion.
- It reported full deployment of net proceeds, leaving no remaining funds.
- The use-of-funds change was endorsed at the annual shareholders’ meeting on April 16, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
